May 17, 2023
(press release)
–
Aptar Pharma, a global leader in drug delivery systems, is pleased to announce a webinar entitled “Approaches to Extractables and Leachables in Parenteral Drugs.” The webinar will provide a comprehensive overview of extractable and leachable testing and its importance in ensuring the safety and efficacy of parenteral drugs. The webinar will cover various aspects of study design, including regulatory guidelines, best practices, equipment, sample preparation, storage conditions, and interpretation of results in the context of specific products and applications. A case study will also be presented, highlighting how extractables, leachables, and other stability studies collaborate in the design and execution of a successful E&L study. Attendees will discover how partnering with Gateway Analytical, an Aptar Pharma company, can help reduce the risk of getting their product to market. The webinar will be of interest to R&D professionals, analytical chemists, project management, manufacturing, quality control, quality assurance, packaging engineers, packaging specialists, and product development globally. The webinar will be held on June 22nd, 2023. Registration is free and can be completed online by clicking on the links below. Register for 9am London Session Register for 3:30pm London Session About Aptar Pharma Aptar Pharma is part of AptarGroup, Inc., a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions and services. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective technologies for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has approximately 13,500 dedicated employees in 20 countries. About Gateway Analytical Gateway Analytical, an Aptar Pharma Company, is a specialized analytical testing laboratory that businesses around the world trust to provide solutions for their most challenging foreign particulate characterization and materials analysis needs. Gateway Analyticals expert scientists, specialized test methods and comprehensive suite of instrumentation deliver the fast, accurate and reliable results that customers in the pharmaceutical, materials and medical device industries demand. With a strong focus on quality, Gateway Analytical is cGMP-compliant, FDA registered and inspected, and DEA licensed. 
For more information, visit www.aptar.com/pharmaceutical
For more information, visit www.gatewayanalytical.com
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
